FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002241684> ?p ?o ?g. }

• W2002241684 endingPage "164" @default.
• W2002241684 startingPage "158" @default.
• W2002241684 abstract "Objectives The Levitronix CentriMag ventricular assist device (VAD) is a centrifugal pump designed for short-term extracorporeal support in cardiogenic shock. The aim of this study is to report our clinical experience with the Levitronix CentriMag for uni- and biventricular support. Methods Between July 2004 and December 2006, 27 patients were supported using the Levitronix CentriMag device. Nineteen were male. Mean age was 47.9 (range 19 to 72) years. Indications for support at implantation were cardiogenic shock that included: end-stage heart failure and too ill to undergo transplantation, with questionable neurologic status (9 subjects); right ventricular failure after left VAD (LVAD) implantation (5 subjects); post-cardiotomy status (7 subjects); and acute donor graft failure after heart transplantation (6 subjects). Results Post-VAD 30-day survival was 30% (8 patients). Mean support time was 11 days for all patients (range 1 to 51 days). Mean support time for 14 Levitronix biventricular VADs was 11 (range 1 to 51) days. Mean support time for 7 Levitronix LVADs was 13.7 (range 1 to 30) days. The highest survival rates after Levitronix support were after donor graft failure (50%) and after cardiotomy (42%). Levitronix right VAD (RVAD) support after long-term LVAD insertion incurred 100% hospital mortality. Of those who survived, 8 patients were discharged home after VAD support and remain alive to date. Two patients were bridged to primary and another bridged to repeat heart transplantation. Five patients were weaned to recovery. Re-operation for bleeding occurred in 8 patients, clinical evidence of cerebral thromboembolism in 3, overwhelming sepsis in 1, and aortic thrombus formation in 1. Clot formation in the tubing was observed in 1 patient, necessitating emergent replacement at bedside, which was successful. Conclusions The Levitronix CentriMag system is a reliable and facile temporary circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock. The Levitronix CentriMag ventricular assist device (VAD) is a centrifugal pump designed for short-term extracorporeal support in cardiogenic shock. The aim of this study is to report our clinical experience with the Levitronix CentriMag for uni- and biventricular support. Between July 2004 and December 2006, 27 patients were supported using the Levitronix CentriMag device. Nineteen were male. Mean age was 47.9 (range 19 to 72) years. Indications for support at implantation were cardiogenic shock that included: end-stage heart failure and too ill to undergo transplantation, with questionable neurologic status (9 subjects); right ventricular failure after left VAD (LVAD) implantation (5 subjects); post-cardiotomy status (7 subjects); and acute donor graft failure after heart transplantation (6 subjects). Post-VAD 30-day survival was 30% (8 patients). Mean support time was 11 days for all patients (range 1 to 51 days). Mean support time for 14 Levitronix biventricular VADs was 11 (range 1 to 51) days. Mean support time for 7 Levitronix LVADs was 13.7 (range 1 to 30) days. The highest survival rates after Levitronix support were after donor graft failure (50%) and after cardiotomy (42%). Levitronix right VAD (RVAD) support after long-term LVAD insertion incurred 100% hospital mortality. Of those who survived, 8 patients were discharged home after VAD support and remain alive to date. Two patients were bridged to primary and another bridged to repeat heart transplantation. Five patients were weaned to recovery. Re-operation for bleeding occurred in 8 patients, clinical evidence of cerebral thromboembolism in 3, overwhelming sepsis in 1, and aortic thrombus formation in 1. Clot formation in the tubing was observed in 1 patient, necessitating emergent replacement at bedside, which was successful. The Levitronix CentriMag system is a reliable and facile temporary circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock." @default.
• W2002241684 created "2016-06-24" @default.
• W2002241684 creator A5007231471 @default.
• W2002241684 creator A5044872358 @default.
• W2002241684 creator A5050551825 @default.
• W2002241684 creator A5053806008 @default.
• W2002241684 creator A5055658877 @default.
• W2002241684 creator A5064124360 @default.
• W2002241684 creator A5066813430 @default.
• W2002241684 date "2008-02-01" @default.
• W2002241684 modified "2023-09-26" @default.
• W2002241684 title "The Papworth Experience With the Levitronix CentriMag Ventricular Assist Device" @default.
• W2002241684 cites W2004595296 @default.
• W2002241684 cites W2024487742 @default.
• W2002241684 cites W2032502194 @default.
• W2002241684 cites W2059978414 @default.
• W2002241684 cites W2074940116 @default.
• W2002241684 cites W2077506428 @default.
• W2002241684 cites W2080895900 @default.
• W2002241684 cites W2089824365 @default.
• W2002241684 cites W2090779444 @default.
• W2002241684 cites W2119804670 @default.
• W2002241684 cites W2121218824 @default.
• W2002241684 cites W2143866530 @default.
• W2002241684 cites W2153525703 @default.
• W2002241684 cites W2159509345 @default.
• W2002241684 cites W2266250508 @default.
• W2002241684 cites W2435454806 @default.
• W2002241684 cites W3095248368 @default.
• W2002241684 cites W4239750414 @default.
• W2002241684 doi "https://doi.org/10.1016/j.healun.2007.10.015" @default.
• W2002241684 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18267221" @default.
• W2002241684 hasPublicationYear "2008" @default.
• W2002241684 type Work @default.
• W2002241684 sameAs 2002241684 @default.
• W2002241684 citedByCount "95" @default.
• W2002241684 countsByYear W20022416842012 @default.
• W2002241684 countsByYear W20022416842013 @default.
• W2002241684 countsByYear W20022416842014 @default.
• W2002241684 countsByYear W20022416842015 @default.
• W2002241684 countsByYear W20022416842016 @default.
• W2002241684 countsByYear W20022416842017 @default.
• W2002241684 countsByYear W20022416842018 @default.
• W2002241684 countsByYear W20022416842019 @default.
• W2002241684 countsByYear W20022416842020 @default.
• W2002241684 countsByYear W20022416842022 @default.
• W2002241684 countsByYear W20022416842023 @default.
• W2002241684 crossrefType "journal-article" @default.
• W2002241684 hasAuthorship W2002241684A5007231471 @default.
• W2002241684 hasAuthorship W2002241684A5044872358 @default.
• W2002241684 hasAuthorship W2002241684A5050551825 @default.
• W2002241684 hasAuthorship W2002241684A5053806008 @default.
• W2002241684 hasAuthorship W2002241684A5055658877 @default.
• W2002241684 hasAuthorship W2002241684A5064124360 @default.
• W2002241684 hasAuthorship W2002241684A5066813430 @default.
• W2002241684 hasConcept C126322002 @default.
• W2002241684 hasConcept C141071460 @default.
• W2002241684 hasConcept C164705383 @default.
• W2002241684 hasConcept C2776850375 @default.
• W2002241684 hasConcept C2778198053 @default.
• W2002241684 hasConcept C2778774980 @default.
• W2002241684 hasConcept C2778849806 @default.
• W2002241684 hasConcept C2778881276 @default.
• W2002241684 hasConcept C2779915274 @default.
• W2002241684 hasConcept C2780142773 @default.
• W2002241684 hasConcept C2911091166 @default.
• W2002241684 hasConcept C500558357 @default.
• W2002241684 hasConcept C71924100 @default.
• W2002241684 hasConceptScore W2002241684C126322002 @default.
• W2002241684 hasConceptScore W2002241684C141071460 @default.
• W2002241684 hasConceptScore W2002241684C164705383 @default.
• W2002241684 hasConceptScore W2002241684C2776850375 @default.
• W2002241684 hasConceptScore W2002241684C2778198053 @default.
• W2002241684 hasConceptScore W2002241684C2778774980 @default.
• W2002241684 hasConceptScore W2002241684C2778849806 @default.
• W2002241684 hasConceptScore W2002241684C2778881276 @default.
• W2002241684 hasConceptScore W2002241684C2779915274 @default.
• W2002241684 hasConceptScore W2002241684C2780142773 @default.
• W2002241684 hasConceptScore W2002241684C2911091166 @default.
• W2002241684 hasConceptScore W2002241684C500558357 @default.
• W2002241684 hasConceptScore W2002241684C71924100 @default.
• W2002241684 hasIssue "2" @default.
• W2002241684 hasLocation W20022416841 @default.
• W2002241684 hasLocation W20022416842 @default.
• W2002241684 hasOpenAccess W2002241684 @default.
• W2002241684 hasPrimaryLocation W20022416841 @default.
• W2002241684 hasRelatedWork W1971244460 @default.
• W2002241684 hasRelatedWork W2002241684 @default.
• W2002241684 hasRelatedWork W2061476159 @default.
• W2002241684 hasRelatedWork W2071103310 @default.
• W2002241684 hasRelatedWork W2080895900 @default.
• W2002241684 hasRelatedWork W2164650516 @default.
• W2002241684 hasRelatedWork W2412475215 @default.
• W2002241684 hasRelatedWork W2553800666 @default.
• W2002241684 hasRelatedWork W4226034152 @default.
• W2002241684 hasRelatedWork W952550617 @default.
• W2002241684 hasVolume "27" @default.
• W2002241684 isParatext "false" @default.

• next